Pharmexa: Interim Report for the First Six Months of 2005


HORSHOLM, Denmark, Aug. 24, 2005 (PRIMEZONE) -- Summary: The Pharmexa Group generated revenue of DKK 1,756 thousand in the first six months of 2005 and realised a net loss of DKK 59,065 thousand. Research and development costs totalled DKK 46,741 thousand. Pharmexa maintains its previous financial forecast for the full year.

Important notice: This is not the complete press release.

To view the complete press release, please see enclosed PDF-file: